Physician profile
Michael Craig Dasinger
NPI 1225261977
$2,241.15
in general payments reported to CMS, 2019-2025
17 companies · $559 in 2025
The $559 reported for 2025 was more than what 80% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $422 · 2020: $336 · 2021: $70.43 · 2022: $366 · 2023: $273 · 2024: $215 · 2025: $559.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,032 · Entertainment: $14.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,032.29 |
| Entertainment | $14.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $457.79 | 2019-2024 | Myday Contact Lens, Clariti Contact Lens |
| Bausch & Lomb Americas INC. | $279.27 | 2022-2025 | Infuse, Vyzulta |
| Alcon Vision LLC | $259.42 | 2021-2025 | Total30, Tryptyr, Dailies |
| Tarsus Pharmaceuticals, INC. | $231.17 | 2025 | Xdemvy |
| Optovue, INC. | $194.10 | 2020 | |
| Sun Pharmaceutical Industries INC. | $186.71 | 2025 | |
| Optos, INC. | $121.15 | 2019-2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Lombart Brothers, INC. | $109.82 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $92.40 | 2019-2023 | Acuvue |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $79.38 | 2019-2020 | |
| Biotissue Holdings INC. | $76.34 | 2019-2024 | |
| Carl Zeiss Meditec Ag | $38.80 | 2020 | |
| Menicon America INC | $35.82 | 2019 | |
| Oyster Point Pharma, INC. | $35.67 | 2023-2025 | Tyrvaya |
| Carl Zeiss Meditec USA, INC. | $17.94 | 2024 | Cirrus Hd-Oct |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dompe US, INC. | $16.29 | 2025 | Oxervate |
| Maculogix, INC. | $9.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Dasinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.